Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012–15) | Zendy

Michael A. Pfaller | Zendy; Matteo Bassetti | Zendy; Leonard R Duncan | Zendy; Mariana Castanheira | Zendy

Open Access

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012–15)

Author(s) -

Michael A. Pfaller,

Matteo Bassetti,

Leonard R Duncan,

Mariana Castanheira

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx009

Subject(s) - meropenem , broth microdilution , microbiology and biotechnology , pseudomonas aeruginosa , tazobactam , cefepime , enterobacteriaceae , medicine , antimicrobial , biology , antibiotics , minimum inhibitory concentration , antibiotic resistance , imipenem , bacteria , escherichia coli , biochemistry , genetics , gene

To evaluate the in vitro activity of ceftolozane/tazobactam and comparators tested against European isolates of Enterobacteriaceae and Pseudomonas aeruginosa from hospitalized patients with urinary tract infection or intraabdominal infections.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research